Immunotherapy Updates Unlocked: An Interactive Digital Engagement Showcase
Watch live to hear the latest current and emerging clinical data on the use of immunotherapy in patients with melanoma, hepatocellular carcinoma (HCC), and l…
Watch live to hear the latest current and emerging clinical data on the use of immunotherapy in patients with melanoma, hepatocellular carcinoma (HCC), and l…
Journal of Neuro-Oncology – Mutations in the Isocitrate Dehydrogenase (IDH) genes, IDH1 or IDH2, define a group of adult diffuse gliomas associated with a younger…
Yair Lotan, MD, discusses notable up-and-coming agents in the BCG-unresponsive non–muscle-invasive bladder cancer treatment armamentarium.
Jorge Cortes, MD director of the Georgia Cancer Center at Augusta University and inaugural Editor-in-Chief of Blood Global Hematology, shares his vision for the journal…
Do you want to work where you have a voice? Nurses are at the forefront of our commitment to the care and improvement of human…
An abstract is unavailable.
In a tender, romantic gesture, John Clark (Richard Gere) purchases a single red rose before heading to surprise his wife Beverly (Susan Sarandon) at her…
Menin inhibitors are emerging as a promising therapeutic approach in acute myeloid leukemia (AML), particularly in patients with specific genetic…
Nitin Jain, MD, discusses the use of BTK inhibitor– and venetoclax-based regimens for the frontline treatment of chronic lymphocytic leukemia.
The Multiple Myeloma Hub spoke with Paul Richardson, Dana-Farber Cancer Institute, Boston, US. We asked, How do I treat patients with relapsed/refractory multiple myeloma after…